600 institutions reported holding HLN for 2026Q1, together 6.2% of the company, more than the 592 a quarter earlier. Institutions reporting a position: 600 (as of 2026Q1). Shares held by institutions: 557.8M, long US equity positions only, as reported on Form 13F. Reported value: $5.58B, at 2026-03-31 prices, not today's. Top 5 holders: 3.7%, of the whole company, between five filers.

HLNHaleon plc

HealthcareUSD

$10.19

$8.6152 weeks$11.12

Who owns HLN

600 institutions reported holding HLN for 2026Q1, together 6.2% of the company, more than the 592 a quarter earlier.

600

Institutions reporting a position · as of 2026Q1 · up from 592 the quarter before

Shares held by institutions: 557.8M
Shares held by institutions · 6.2% of the company · long US equity positions only, as reported on Form 13F
Reported value: $5.58B
Reported value · at 2026-03-31 prices, not today's
Top 5 holders: 3.7%
Top 5 holders · of the whole company, between five filers

Details›

Reporting quarter2026-03-31: 2026Q1
Quarters on record: 15
New positions: 83
Positions exited: 77
Added to: 196
Reduced: 158
Top 10 holdersof the company: 4.3%

Institutional ownership by quarter, 2022Q3 to 2026Q1
Quarter	Filers	Shares	Reported value
2026Q1	600	557.8M	$5.58B
2025Q4	592	565.7M	$5.79B
2025Q3	586	548.9M	$4.92B
2025Q2	613	576.3M	$5.98B
2025Q1	585	569.6M	$5.86B
2024Q4	595	734.1M	$7.01B
2024Q3	583	515.8M	$5.46B
2024Q2	574	520.1M	$4.30B
2024Q1	592	507.0M	$4.30B
2023Q4	584	394.0M	$3.24B
2023Q3	563	391.2M	$3.26B
2023Q2	572	378.6M	$3.17B
2023Q1	570	370.0M	$3.02B
2022Q4	577	336.4M	$2.69B
2022Q3	545	307.4M	$1.87B

Largest reported holders, 2026Q1
Holder	Shares	% of company	Value
Dodge & Cox	146.5M	1.6%	$1.47B
FMR LLC	114.0M	1.3%	$1.14B
MARTIN CURRIE LTD	31.7M	0.35%	$318M
MORGAN STANLEY	19.2M	0.21%	$192M
Harding Loevner LP	15.7M	0.18%	$157M
HARRIS ASSOCIATES L P	15.0M	0.17%	$150M
ARROWSTREET CAPITAL LIMITED PARTNERSHIP	14.7M	0.16%	$147M
BANK OF AMERICA CORP /DE/	10.9M	0.12%	$109M
JONES FINANCIAL COMPANIES LLLP	9.1M	0.10%	$89M
Nuveen Asset Management, LLC	8.7M	0.10%	$87M

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.

reading the register…

Drug Manufacturers - Specialty & Generic

The closest names by size in the same industry

Compare peers

TEVA-1.8%

Teva Pharmaceutical Industries Limited

TAK-0.45%

Takeda Pharmaceutical Company Limited

ZTS+1.7%

Zoetis

UTHR-1.2%

United Therapeutics Corporation

VTRS+1.1%

Viatris

NBIX-1.1%

Neurocrine Biosciences, Inc.